340 related articles for article (PubMed ID: 7951231)
21. Mutations and allelic loss of the NF2 gene in neurofibromatosis 2-associated skin tumors.
Kluwe L; Friedrich RE; Hagel C; Lindenau M; Mautner VF
J Invest Dermatol; 2000 May; 114(5):1017-21. PubMed ID: 10771486
[TBL] [Abstract][Full Text] [Related]
22. Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2.
Giovannini M; Robanus-Maandag E; van der Valk M; Niwa-Kawakita M; Abramowski V; Goutebroze L; Woodruff JM; Berns A; Thomas G
Genes Dev; 2000 Jul; 14(13):1617-30. PubMed ID: 10887156
[TBL] [Abstract][Full Text] [Related]
23. Molecular biology of vestibular schwannomas.
Chang LS; Welling DB
Methods Mol Biol; 2009; 493():163-77. PubMed ID: 18839347
[TBL] [Abstract][Full Text] [Related]
24. A missense mutation in the NF2 gene results in moderate and mild clinical phenotypes of neurofibromatosis type 2.
Kluwe L; Mautner VF
Hum Genet; 1996 Feb; 97(2):224-7. PubMed ID: 8566958
[TBL] [Abstract][Full Text] [Related]
25. Molecular genetics alterations and tumor behavior of sporadic vestibular schwannoma from the People's Republic of China.
Bian LG; Tirakotai W; Sun QF; Zhao WG; Shen JK; Luo QZ
J Neurooncol; 2005 Jul; 73(3):253-60. PubMed ID: 15980976
[TBL] [Abstract][Full Text] [Related]
26. Molecular genetic analysis of the NF2 gene in young patients with unilateral vestibular schwannomas.
Mohyuddin A; Neary WJ; Wallace A; Wu CL; Purcell S; Reid H; Ramsden RT; Read A; Black G; Evans DG
J Med Genet; 2002 May; 39(5):315-22. PubMed ID: 12011146
[TBL] [Abstract][Full Text] [Related]
27. Identification of three neurofibromatosis type 2 (NF2) gene mutations in vestibular schwannomas.
Sainz J; Figueroa K; Baser ME; Pulst SM
Hum Genet; 1996 Jan; 97(1):121-3. PubMed ID: 8557252
[TBL] [Abstract][Full Text] [Related]
28. Mutation scanning of the NF2 gene: an improved service based on meta-PCR/sequencing, dosage analysis, and loss of heterozygosity analysis.
Wallace AJ; Watson CJ; Oward E; Evans DG; Elles RG
Genet Test; 2004; 8(4):368-80. PubMed ID: 15684865
[TBL] [Abstract][Full Text] [Related]
29. Somatic neurofibromatosis type 2 gene mutations and growth characteristics in vestibular schwannoma.
Irving RM; Harada T; Moffat DA; Hardy DG; Whittaker JL; Xuereb JH; Maher ER
Am J Otol; 1997 Nov; 18(6):754-60. PubMed ID: 9391673
[TBL] [Abstract][Full Text] [Related]
30. NF2 genetic alterations in sporadic vestibular schwannomas: clinical implications.
Lassaletta L; Torres-Martín M; Peña-Granero C; Roda JM; Santa-Cruz-Ruiz S; Castresana JS; Gavilan J; Rey JA
Otol Neurotol; 2013 Sep; 34(7):1355-61. PubMed ID: 23921927
[TBL] [Abstract][Full Text] [Related]
31. Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas.
Hadfield KD; Smith MJ; Urquhart JE; Wallace AJ; Bowers NL; King AT; Rutherford SA; Trump D; Newman WG; Evans DG
Oncogene; 2010 Nov; 29(47):6216-21. PubMed ID: 20729918
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical detection of schwannomin and neurofibromin in vestibular schwannomas, ependymomas and meningiomas.
Huynh DP; Mautner V; Baser ME; Stavrou D; Pulst SM
J Neuropathol Exp Neurol; 1997 Apr; 56(4):382-90. PubMed ID: 9100669
[TBL] [Abstract][Full Text] [Related]
33. Mild familial neurofibromatosis 2 associates with expression of merlin with altered COOH-terminus.
Sainio M; Jääskeläinen J; Pihlaja H; Carpén O
Neurology; 2000 Mar; 54(5):1132-8. PubMed ID: 10720287
[TBL] [Abstract][Full Text] [Related]
34. CNS Young Investigator Award Lecture: molecular analysis of the neurofibromatosis 2 tumor suppressor.
MacCollin M
Brain Dev; 1995; 17(4):231-8. PubMed ID: 7503383
[TBL] [Abstract][Full Text] [Related]
35. Detection of novel NF2 mutations by an RNA mismatch cleavage method.
Faudoa R; Xue Z; Lee F; Baser ME; Hung G
Hum Mutat; 2000; 15(5):474-8. PubMed ID: 10790209
[TBL] [Abstract][Full Text] [Related]
36. Sensitive detection of deletions of one or more exons in the neurofibromatosis type 2 (NF2) gene by multiplexed gene dosage polymerase chain reaction.
Diebold R; Bartelt-Kirbach B; Evans DG; Kaufmann D; Hanemann CO
J Mol Diagn; 2005 Feb; 7(1):97-104. PubMed ID: 15681480
[TBL] [Abstract][Full Text] [Related]
37. Mutational analysis and expression studies of the neurofibromatosis type 2 (NF2) gene in a patient with a ring chromosome 22 and NF2.
Kehrer-Sawatzki H; Udart M; Krone W; Baden R; Fahsold R; Thomas G; Schmucker B; Assum G
Hum Genet; 1997 Jul; 100(1):67-74. PubMed ID: 9225971
[TBL] [Abstract][Full Text] [Related]
38. Universal absence of merlin, but not other ERM family members, in schwannomas.
Stemmer-Rachamimov AO; Xu L; Gonzalez-Agosti C; Burwick JA; Pinney D; Beauchamp R; Jacoby LB; Gusella JF; Ramesh V; Louis DN
Am J Pathol; 1997 Dec; 151(6):1649-54. PubMed ID: 9403715
[TBL] [Abstract][Full Text] [Related]
39. A group of schwannomas with interstitial deletions on 22q located outside the NF2 locus shows no detectable mutations in the NF2 gene.
Bruder CE; Ichimura K; Tingby O; Hirakawa K; Komatsuzaki A; Tamura A; Yuasa Y; Collins VP; Dumanski JP
Hum Genet; 1999 May; 104(5):418-24. PubMed ID: 10394935
[TBL] [Abstract][Full Text] [Related]
40. The neurofibromatosis 2 (NF2) tumour suppressor gene: implications beyond the hereditary tumour syndrome?
Kley N; Seizinger BR
Cancer Surv; 1995; 25():207-18. PubMed ID: 8718520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]